IGEM:IMPERIAL/2008/Bioprinter/Integration: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
(37 intermediate revisions by 2 users not shown)
Line 1: Line 1:
_NOCT_
==Integration in ''B.subtilis''==
==Integration in ''B.subtilis''==




===General Mechanisms===
===General Mechanisms===
[[Image:Integration.PNG|center|thumb|700px| Integration Mechanisms - Picture is adapted from [http://www.bgsc.org Bacillus Genetic Stock Center]]]
[[Image:Integration.PNG|center|thumb|700px| Integration Mechanisms - Picture is adapted from [http://www.bgsc.org Bacillus Genetic Stock Center]]]


===Our Strategy===
===Our Strategy===
We have investigated the use of double crossover events to integrate our genetic devices into ''B.subtilis''. In addition, we want to design integration biobricks, that allow site specific integration of parts and devices into the ''B.subtilis'' chromosome. We aim to create a series of integration bricks that will direct integration into neutral endogenous genes. By inserting into neutral genes our ''B.subtilis'' will still be viable and in addition, we will have a means of phenotypic screening to identify successful integration events.
We have investigated the use of double crossover events to integrate our genetic devices into ''B.subtilis''. In addition, we want to design integration biobricks, that allow site specific integration of parts and devices into the ''B.subtilis'' chromosome. We aim to create a series of integration bricks that will direct integration into neutral endogenous genes. By inserting into neutral genes our ''B.subtilis'' will still be viable and in addition, we will have a means of phenotypic screening to identify successful integration events.
<br>
<br>
<br>
<br>
{| border="1" cellpadding="2" style="text-align:left"
{| border="1" cellpadding="2" style="text-align:left"
|-
|-
||'''Gene'''
|style="background:#dddddd;" | '''Gene'''
||'''Phenotypic Marker'''
|style="background:#dddddd;" |'''Phenotypic Marker'''
||'''Sequence'''
|style="background:#dddddd;" |'''Sequence'''
|-
|-
| PyrD || Growth Media needs to <br> be supplemented with uracil  ||  [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU15540 Sequence]
|'''''PyrD''''' - dihydroorotate dehydrogenase 1B || '''Growth Media needs to be supplemented with uracil''' - Uracil needs to be added to a final concentration of 40μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement <cite>sites</cite> ||  [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU15540 Sequence]
|-
|-
| GltA || Growth Media needs to <br> be supplemented with glutamate  || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU18450 Sequence]
| '''''GltA''''' - glutamate synthase ||'''Growth Media needs to be supplemented with glutamate''' - Glutamate needs to be added to a final concentration of 500μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement <cite>sites</cite>   || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU18450 Sequence]
|-
|-
| SacA || Growth Media needs to <br> contain glucose as a carbon source,<br> not sucrose  || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU38040 Sequence]  
| '''''SacA''''' - sucrase-6-phosphate hydrolase  || '''Growth Media needs to contain glucose as a carbon source''' - Transformants can only grow on minimal media containing glucose as a carbon source not sucrose. This means we would need to be careful what type of media we culture our cells in <cite>sites</cite> || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU38040 Sequence]  
|-
|-
| AmyE || Disruption of α-amylase ||  [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU03040 Sequence]
| '''''AmyE''''' - alpha-amylase  || '''Disruption of α-amylase''' - Transformants have to be grown on plates overnight and then stained with Grams iodine solution and incubated for a few minutes. Clear rings will form around colonies containing the amylase gene.Colonies without significant zones of clearing are amylase negative, and therefore presumed to be amy knockouts <cite>protocol</cite> ||  [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU03040 Sequence]
|-
|-
| ThrC || Threonine auxotropy || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU32250 Sequence]
| '''''ThrC''''' - threonine synthase  || '''Threonine auxotropy''' Threonine needs to be added to a final concentration of 50μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement <cite>Threonine</cite> (N.B.Find More e.g. Protocols) || [http://www.genome.jp/dbget-bin/www_bget?bsu:BSU32250 Sequence]
|-
|-
|}
|}
<br>
<br>


===Key issues===
===Key issues===
*How long homology is required
 
*Promoter upstream?
'''''How long does the homologous sequence need to be for integration?'''''
*Directionalilty
<br>
*Max length for one site- probably fins examples
The integration vectors that are currently available contain two regions of homology to allow for double crossover events. These regions are typically made from the whole gene sequence, i.e. the 5' homology sequence corresponds the 5' half of the gene and the 3' homology sequence corresponds to the 3' half of the gene. This means that typically the regions of homology for a vector are between 500bp to 2000bp. Because we will be using DNA synthesis to construct our integration parts we are limited to size and use of integration parts greater than a few hundred bp is unfeasible. <br>
*Assembly
An early paper claimed that the minimal length of homology required was only 70bp <cite>length</cite>. However, a more recent paper has shown that 150bp was the minimal length of homology required for integration <cite>length2</cite>
<br>
<br>
'''''How do we maintain the correct orientation?'''''
<br>
For the integrated devices to be expressed we need to make sure that they are integrated correctly in the 5' to 3' direction. Because we are using the double crossover integration orientation is easy to maintain because the two flanking integration sequences ensure correct orientation of integration.
<br>
<br>
'''''What is the effect of integration site on gene expression?'''''
<br>
A study using the ''PyrD'', ''GltA'' and ''ThrC'' integration sites has shown that there is no significant difference in the levels of gene expression between these different sites of integration <cite>sites</cite>.
<br>
<br>
 
'''''Maximum length of DNA that we can integrate?'''''
<br>
There have been various estimations over the maximum length of DNA that can be stability incorporated into the ''B.subtilis'' chromosome. There estimations vary from 10kb to 16kb for double homologous cross over events <cite>length3</cite>. For us it is unlikely that our design will contain more than a few genes in tandem and so we should not exceed 2-3kb for each construct.       
<br>
<br>
 
'''''Transcriptional Read through'''''
 
<br>
<br>
 
===References===
<biblio>
#sites pmid=15109830
#bgsc www.bgsc.org
#Threonine pmid=10464210
#length pmid=1406596
#length2 pmid=9846745
#length3 pmid=8246882
#length4 pmid=11056400
#length5 pmid=14663629
#length6 pmid=12366828
#length7 pmid=3924889
#length8 pmid=18066072
 
</biblio>

Latest revision as of 10:08, 8 August 2008

Integration in B.subtilis

General Mechanisms

Integration Mechanisms - Picture is adapted from Bacillus Genetic Stock Center

Our Strategy

We have investigated the use of double crossover events to integrate our genetic devices into B.subtilis. In addition, we want to design integration biobricks, that allow site specific integration of parts and devices into the B.subtilis chromosome. We aim to create a series of integration bricks that will direct integration into neutral endogenous genes. By inserting into neutral genes our B.subtilis will still be viable and in addition, we will have a means of phenotypic screening to identify successful integration events.

Gene Phenotypic Marker Sequence
PyrD - dihydroorotate dehydrogenase 1B Growth Media needs to be supplemented with uracil - Uracil needs to be added to a final concentration of 40μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement [1] Sequence
GltA - glutamate synthase Growth Media needs to be supplemented with glutamate - Glutamate needs to be added to a final concentration of 500μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement [1] Sequence
SacA - sucrase-6-phosphate hydrolase Growth Media needs to contain glucose as a carbon source - Transformants can only grow on minimal media containing glucose as a carbon source not sucrose. This means we would need to be careful what type of media we culture our cells in [1] Sequence
AmyE - alpha-amylase Disruption of α-amylase - Transformants have to be grown on plates overnight and then stained with Grams iodine solution and incubated for a few minutes. Clear rings will form around colonies containing the amylase gene.Colonies without significant zones of clearing are amylase negative, and therefore presumed to be amy knockouts [2] Sequence
ThrC - threonine synthase Threonine auxotropy Threonine needs to be added to a final concentration of 50μg/ml to allow growth. This means that we would need to do a form of replica plating and compare which colonies cannot grow without this supplement [3] (N.B.Find More e.g. Protocols) Sequence



Key issues

How long does the homologous sequence need to be for integration?
The integration vectors that are currently available contain two regions of homology to allow for double crossover events. These regions are typically made from the whole gene sequence, i.e. the 5' homology sequence corresponds the 5' half of the gene and the 3' homology sequence corresponds to the 3' half of the gene. This means that typically the regions of homology for a vector are between 500bp to 2000bp. Because we will be using DNA synthesis to construct our integration parts we are limited to size and use of integration parts greater than a few hundred bp is unfeasible.
An early paper claimed that the minimal length of homology required was only 70bp [4]. However, a more recent paper has shown that 150bp was the minimal length of homology required for integration [5]

How do we maintain the correct orientation?
For the integrated devices to be expressed we need to make sure that they are integrated correctly in the 5' to 3' direction. Because we are using the double crossover integration orientation is easy to maintain because the two flanking integration sequences ensure correct orientation of integration.

What is the effect of integration site on gene expression?
A study using the PyrD, GltA and ThrC integration sites has shown that there is no significant difference in the levels of gene expression between these different sites of integration [1].

Maximum length of DNA that we can integrate?
There have been various estimations over the maximum length of DNA that can be stability incorporated into the B.subtilis chromosome. There estimations vary from 10kb to 16kb for double homologous cross over events [6]. For us it is unlikely that our design will contain more than a few genes in tandem and so we should not exceed 2-3kb for each construct.

Transcriptional Read through



References

  1. Middleton R and Hofmeister A. New shuttle vectors for ectopic insertion of genes into Bacillus subtilis. Plasmid. 2004 May;51(3):238-45. DOI:10.1016/j.plasmid.2004.01.006 | PubMed ID:15109830 | HubMed [sites]
  2. Resnekov O. Role of the sporulation protein BofA in regulating activation of the Bacillus subtilis developmental transcription factor sigmaK. J Bacteriol. 1999 Sep;181(17):5384-8. DOI:10.1128/JB.181.17.5384-5388.1999 | PubMed ID:10464210 | HubMed [Threonine]
  3. Khasanov FK, Zvingila DJ, Zainullin AA, Prozorov AA, and Bashkirov VI. Homologous recombination between plasmid and chromosomal DNA in Bacillus subtilis requires approximately 70 bp of homology. Mol Gen Genet. 1992 Sep;234(3):494-7. DOI:10.1007/BF00538711 | PubMed ID:1406596 | HubMed [length]
  4. Vagner V, Dervyn E, and Ehrlich SD. A vector for systematic gene inactivation in Bacillus subtilis. Microbiology (Reading). 1998 Nov;144 ( Pt 11):3097-3104. DOI:10.1099/00221287-144-11-3097 | PubMed ID:9846745 | HubMed [length2]
  5. Itaya M. Integration of repeated sequences (pBR322) in the Bacillus subtilis 168 chromosome without affecting the genome structure. Mol Gen Genet. 1993 Nov;241(3-4):287-97. DOI:10.1007/BF00284680 | PubMed ID:8246882 | HubMed [length3]
  6. www.bgsc.org

    [bgsc]
  7. Itaya M, Nagata T, Shiroishi T, Fujita K, and Tsuge K. Efficient cloning and engineering of giant DNAs in a novel Bacillus subtilis genome vector. J Biochem. 2000 Nov;128(5):869-75. DOI:10.1093/oxfordjournals.jbchem.a022825 | PubMed ID:11056400 | HubMed [length4]
  8. Yakhnin H and Babitzke P. Gene replacement method for determining conditions in which Bacillus subtilis genes are essential or dispensable for cell viability. Appl Microbiol Biotechnol. 2004 Apr;64(3):382-6. DOI:10.1007/s00253-003-1502-5 | PubMed ID:14663629 | HubMed [length5]
  9. Fabret C, Ehrlich SD, and Noirot P. A new mutation delivery system for genome-scale approaches in Bacillus subtilis. Mol Microbiol. 2002 Oct;46(1):25-36. DOI:10.1046/j.1365-2958.2002.03140.x | PubMed ID:12366828 | HubMed [length6]
  10. Niaudet B, Jannière L, and Ehrlich SD. Integration of linear, heterologous DNA molecules into the Bacillus subtilis chromosome: mechanism and use in induction of predictable rearrangements. J Bacteriol. 1985 Jul;163(1):111-20. DOI:10.1128/jb.163.1.111-120.1985 | PubMed ID:3924889 | HubMed [length7]
  11. Itaya M, Fujita K, Kuroki A, and Tsuge K. Bottom-up genome assembly using the Bacillus subtilis genome vector. Nat Methods. 2008 Jan;5(1):41-3. DOI:10.1038/nmeth1143 | PubMed ID:18066072 | HubMed [length8]

All Medline abstracts: PubMed | HubMed